Enzyme inhibitors and enzyme substrates

Pelitinib (EKB-569) is a potent irreversible EGFR inhibitor with IC50 of 38.5 nM.An EGFR inhibitor.

Pelitinib (EKB-569) is a potent irreversible EGFR inhibitor with IC50 of 38.5 nM.An EGFR inhibitor.

Pelitinib (EKB-569) is a potent irreversible EGFR inhibitor with IC50 of 38.5 nM.An EGFR inhibitor.

Pelitinib (EKB-569) is a potent irreversible EGFR inhibitor with IC50 of 38.5 nM.An EGFR inhibitor.

Piroxicam is a non-selective COX inhibitor with an IC50 of 6 mM.An inhibitor of prostaglandin synthesis as well as Cox-1 and Cox-2.

Piroxicam is a non-selective COX inhibitor with an IC50 of 6 mM.An inhibitor of prostaglandin synthesis as well as Cox-1 and Cox-2.

Piroxicam is a non-selective COX inhibitor with an IC50 of 6 mM.An inhibitor of prostaglandin synthesis as well as Cox-1 and Cox-2.

Piroxicam is a non-selective COX inhibitor with an IC50 of 6 mM.An inhibitor of prostaglandin synthesis as well as Cox-1 and Cox-2.

Piroxicam is a non-selective COX inhibitor with an IC50 of 6 mM.An inhibitor of prostaglandin synthesis as well as Cox-1 and Cox-2.

PMSF Solution.

PMSF Solution.

Pomalidomide inhibits LPS-induced TNF-α release with IC50 of 13 nM.Pomalidomide is a second generation immunomodulator, TNF-α inhibitor, and thalidomide analog. An inhibitor of LPS-induced TNFαrelease.